Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
100Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $32.04M | $-46.50M | $-1.41 |
Social Signal Score
Earnings
Typical surprise +20.8% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 11$-1.10 vs $-0.71miss
- Thu, Jun 4$-0.53 vs $-18.79beat
Estimates and results for MOBI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
MOBIhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (2)
- Newsseekingalpha.com·3d ago·Positive
Mobia Medical, Inc. (MOBI) Q2 2026 Earnings Call Transcript Mobia Medical, Inc. (MOBI) Q2 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·3d ago·Negative
Mobia Medical Q2 Earnings Call Highlights Mobia Medical NASDAQ: MOBI reported second-quarter revenue of $13.5 million, up 102% from $6.7 million a year earlier, as adoption of its Vivistim paired vagus nerve stimulation therapy expanded across new and existing stroke-care programs.
View source ↗
